BAP1 and cutaneous melanoma: The second patient had a personal history of cutaneous melanoma, a family history of cutaneous and uveal melanoma, and over 7 years of follow‐up, developed four additional BAP1‐inactivated melanocytic tumours (BIMTs) confirmed by IHC.